Navigation Links
ReproCELL Launches Alzheimer's Disease Model Based on iPS-derived Human Neuronal Cells
Date:6/7/2012

YOKOHAMA, Japan, June 7, 2012 /PRNewswire/ --

ReproCELL, Inc. (CEO: Chikafumi Yokoyama PhD) announces today that the company will start commercializing human iPS-derived neurons in which an Alzheimer's disease related gene has been incorporated.

ReproCELL's scientists have successfully incorporated a gene related to Alzheimer's disease using homologous recombinant genetic engineering technology into undifferentiated human iPS cells and then differentiated them into neurons. In these cells, it has been confirmed that amyloid beta 42 is accumulated at higher levels compared to normal neurons. This phenomena is similar to what is observed in neurons of Alzheimer's patients. Accordingly, ReproCELL's scientists believe the newly developed iPS cells can be useful for drug screening to identify new therapeutic molecules to treat Alzheimer's disease patients.

The company will start marketing the cells on June 13th, 2012.

Details of data of the cells will be announced at the 10th annual meeting of ISSCR (International Society for Stem Cell Research) at Yokohama, Japan (June 13th-16th, 2012).

ReproCELL is a world-leading pioneer in commercializing human pluripotent stem cells as an effective tool for drug discovery and development. The company has successfully launched iPS-derived cardiomyocytes for cardiac toxicity testing, followed by the launch of iPS-derived dopaminergic neurons and hepatocytes for efficacy and toxicity screening of drug candidates.

This is the fourth product of the company using iPS technology and the first cellular disease model incorporating a disease-related gene.

Contact: info_en@reprocell.com Tel: 81-(0)45-475-3887
KDX Shin-Yokohama 381 bldg. 8F, 3-8-11 Shin-Yokohama, Kohoku-ku,
Yokohama, Kanagawa 222-0033, Japan


'/>"/>
SOURCE ReproCELL, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cellular Dynamics Launches MyCell™ Services
2. Kansas City Region Launches Contract Research Initiative To Speed The Development Of Health Care Innovation Worldwide
3. The Medical Letter Launches More@MedLetter
4. The official blog of The Medical Letter
5. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
6. Glooko Launches the Glooko™ IR Adapter to Give ACCU-CHEK® Blood Glucose Meter Customers Access to the Glooko Logbook Solution
7. Mylan Launches Generic Version of Lipitor®
8. Cardinal Health Specialty Solutions Launches PathWare™ Decision Support Transaction Solutions
9. Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy
10. Mylan Launches Generic Version of Viramune® Tablets
11. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... ... , ... People across the U.S. are sharpening their pencils and honing their ... in which patients and their families pay tribute to a genetic counselor by nominating ... of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, ...
Breaking Medicine News(10 mins):